gantacurium Report issue

Small molecule Experimental
AACT ChEMBL DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now
Gantacurium chloride is a new experimental neuromuscular blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in surgical anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Gantacurium is not yet available for widespread clinical use: it is currently undergoing Phase III clinical development.   Wikipedia

Chemistry

  • SMILES: COc1cc2CC[N@@+](C)(CCCOC(=O)\C(=C\C(=O)OCCC[N@@+]3(C)CCc4cc(OC)c(OC)cc4[C@@H]3c5cc(OC)c(OC)c(OC)c5)\Cl)[C@H](Cc6cc(OC)c(OC)c(OC)c6)c2cc1OC
  • InChIKey: ZQLDXCSTJFLRPY-RWBXLJKRSA-N
  • Mol. Mass: 993.59
  • ALogP: 7.84
  • ChEMBL Molecules:
    gantacurium  
    gantacurium chloride  
More Chemistry

Pharmacology

Alternative names

av430a | cw 002 | gantacurium | gantacurium chloride | gw280430a | gw 280430a | gw-280430a

Organizations (3)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Healthy Volunteers (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue